Close Menu

NEW YORK (GenomeWeb) – New research has helped illuminate how physicians are using Genomic Health's Oncotype DX to guide treatment decision-making for women with early-stage breast cancer: whether they tend to order the test in the correct circumstances, and how they then act on the results.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.